These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15452000)

  • 1. Advocating for medical diplomacy: a conversation with Tommy G. Thompson.
    Thompson TG
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-262-8. PubMed ID: 15452000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yielding the bully pulpit: a conversation with Tommy Thompson. Interview by John K Iglehart.
    Thompson T
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-225-W5-232. PubMed ID: 15886146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bias toward action: a conversation with Leonard Schaeffer. Interview by John K. Iglehart.
    Schaeffer L
    Health Aff (Millwood); 2001; Suppl Web Exclusives():W30-8. PubMed ID: 11911323
    [No Abstract]   [Full Text] [Related]  

  • 4. Grasping the role of technology: a conversation with Ron Dollens. Interview by John K. Iglehart.
    Dollens R
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-296-W5-313. PubMed ID: 15975988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a global health diplomacy supply chain--a viable option for the United States to curb extremism.
    Kumar S; Honkanen EJ; Karl CC
    J Health Commun; 2009; 14(7):674-89. PubMed ID: 19851918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making a difference in differences for the health inequalities of individuals.
    Miller T
    Health Aff (Millwood); 2007; 26(5):1235-7. PubMed ID: 17848431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How useful is 'vulnerable' as a concept?
    Vladeck BC
    Health Aff (Millwood); 2007; 26(5):1231-4. PubMed ID: 17848430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congress presses forward with health care agenda despite international focus on Iraq.
    Van Koevering M
    Healthplan; 2003; 44(3):10-2, 14. PubMed ID: 12808753
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare program; Medicare prescription drug discount card; revision of marketing rules for endorsed drug card sponsors. Final rule.
    Centers for Medicare & Medicaid Services, HHS
    Fed Regist; 2005 Sep; 70(169):52019-23. PubMed ID: 16138430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretary Thompson promotes Medicare modernization.
    Health Care Financ Rev; 2001; 22(4):203. PubMed ID: 12378768
    [No Abstract]   [Full Text] [Related]  

  • 11. Immigrants and health care: sources of vulnerability.
    Derose KP; Escarce JJ; Lurie N
    Health Aff (Millwood); 2007; 26(5):1258-68. PubMed ID: 17848435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health insurance, the uninsured, and hospitals: collision course.
    Friedman E
    Front Health Serv Manage; 2005; 21(4):3-15. PubMed ID: 16028498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Final rule.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 Dec; 69(239):74451-3. PubMed ID: 15597491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing policy issues in Medicare prescription drug coverage.
    Cubanski J
    Issue Brief (Commonw Fund); 2004 Nov; (710):1-5. PubMed ID: 15597515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in private insurance, Medicaid/State Children's Health Insurance Program, and the Healthcare Safety Net: implications for vulnerable populations and health disparities.
    Shields AE; McGinn-Shapiro M; Fronstin P
    Ann N Y Acad Sci; 2008; 1136():137-48. PubMed ID: 18579880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public preferences and organized interests in health policy: state pharmacy assistance programs as innovations.
    Gray V; Lowery D; Godwin EK
    J Health Polit Policy Law; 2007 Feb; 32(1):89-129. PubMed ID: 17312326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Savings in the cards: picking the best Medicare drug discount card is tougher than ever.
    Hobson K
    US News World Rep; 2004 Sep; 137(9):52, 56, 58 passim. PubMed ID: 15484836
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving access through health insurance coverage and safety net expansion: a review of the literature.
    Roby DH; Kominski GF; Cameron ME
    Policy Brief UCLA Cent Health Policy Res; 2007 Aug; (PB2007-10):1-6. PubMed ID: 18030692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.